NCT07661914

Brief Summary

The goal of this study is to look at how good artificial intelligence (AI) assisted colonoscopy is compared to conventional colonoscopy in detecting polyps when used by gastroenterology fellows. The main question the study aims to answer are: Does AI assisted colonoscopy improve adenoma detection rate for gastroenterology fellows in different levels of training? Does AI assisted colonoscopy improve other quality indicators such as sessile serrated lesion detection rate withdrawal time? This research will compare these quality measures for gastroenterology fellows in their first, second, and third year of training. The gastroenterology fellows performing colonoscopies will be randomized to either AI assisted colonoscopy or conventional colonoscopy for each case. The nurse in the room will then turn on the AI device if needed and the rest of the colonoscopy will be completed as normal. The procedure notes will indicated whether AI device was used or not during the procedure.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Apr 2026Jul 2027

Study Start

First participant enrolled

April 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2027

Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

June 9, 2026

Last Update Submit

June 16, 2026

Conditions

Keywords

AI assisted colonoscopyGI Genius

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    We hypothesize that an AI assisted colonoscopy done by a gastroenterology fellow will have a higher ADR as compared to conventional colonoscopy done by the same fellow and these results will be more significant among junior fellows compared to senior fellows.

    over 18 months

Secondary Outcomes (2)

  • Sessile serrated lesion detection rate

    Over 18 months

  • Withdrawal time

    Over 18 months

Study Arms (2)

AI assisted colonoscopy

EXPERIMENTAL

GI fellows in this arm will complete colonoscopies with the assistance of AI device GI Genius.

Device: AI assisted colonoscopy

Conventional colonoscopy

ACTIVE COMPARATOR

GI fellows in this arm will complete colonoscopy in a conventional manner

Other: Conventional Colonoscopy

Interventions

The gastroenterology fellows assigned to AI assisted colonoscopy will use the GI genius device while performing colonoscopies.

AI assisted colonoscopy

The gastroenterology fellows assigned to conventional colonoscopy will be performing colonoscopies without the use of AI device.

Conventional colonoscopy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All adult gastroenterology fellows at the University of Oklahoma, except for the fellow conducting research will be included in the study.

You may not qualify if:

  • All patients undergoing colonoscopy for genetic cancer syndromes (ex: polyposis), inflammatory bowel disease, for therapy of known neoplasms or undergoing non-colonoscopy screening tests (fecal immunochemical test, CT colonography) will be excluded from this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma City VA Health Care System

Oklahoma City, Oklahoma, 73104, United States

Location

Study Officials

  • Mohammad Madhoun

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: In this study each gastroenterology fellow will be randomized to either AI assisted colonoscopy arm vs conventional colonoscopy for each case. Thus each fellow will function as his or her own control.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 22, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

July 30, 2027

Last Updated

June 22, 2026

Record last verified: 2026-06

Locations